Alto Neuroscience ANRO
NYSE ANRO
$22.22 -1.10 (-4.74%)
As of: Oct 22, 2026 · 3:59 PM EDT

Alto Neuroscience (ANRO) Ending Cash Balance (2023 - 2026)

Updated

Analysis

Alto Neuroscience (ANRO) Ending Cash Balance (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 6.57 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 4.88 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.03 Bn
10 Alto Neuroscience 957.30 Mn 135.50 Mn - 244.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 244.23 Mn
Mar 31, 2026 264.26 Mn
Dec 31, 2025 176.98 Mn
Sep 30, 2025 138.32 Mn
Jun 30, 2025 148.09 Mn
Mar 31, 2025 161.25 Mn
Dec 31, 2024 168.73 Mn
Sep 30, 2024 182.20 Mn
Jun 30, 2024 193.62 Mn
Mar 31, 2024 205.90 Mn
Dec 31, 2023 82.55 Mn
Sep 30, 2023 51.29 Mn
Jun 30, 2023 59.03 Mn
Mar 31, 2023 65.78 Mn
API Access

Alto Neuroscience Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ANRO&period=max&api_key=YOUR_API_KEY